9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)
暂无分享,去创建一个
N. Pavlakis | L. Crinò | N. Thatcher | P. Garrido | M. Reck | J. Laskin | F. Griesinger | É. Dansin | C. Tsai | C. Schneider